Pharma M2R Minds 2012
From Maintenance to Reliability – Holistic and sophisticated approaches & solutions
5th & 6th November 2012 / MARITIM PROARTE HOTEL BERLIN / Germany
(firmenpresse) - conference Pharma M2R Minds 2012 - From Maintenance to Reliability, which will take place on November 5th – 6th 2012 in Berlin / Germany.
Meet with experts from across the globe to expand your network and discuss current challenges and solutions with 20 renowned knowledgeable experts from international corporations.
• Network in over 20 interactive Sessions with more than 70 key industry leaders and discuss solutions with leading companies like Bayer AG, Baxter BioScience, Abbott Laboratories, DSM, TechOps Merck Serono, Sanofi Pasteur etc.
• Watching this short video of one of our last conferences is a must! It shows why we are different and striving to be the best (http://www.youtube.com/watch?v=XSe4bVl1pZI)
In the following section is an excerpt from our program:
The Pharma M2R Minds 2012 will focus on:
- RCM – Reliability centred maintenance & FMEA – Failure mode & effects analysis
- Performing End-to-End root cause analysis using SAP – how to make the most of root cause analysis to progressively eliminate failures
- RCA – Essential elements of asset integrity management and reliability centred maintenance procedures
- Shutdown & Turnaround management in a GMP & validated environment
- Operational excellence, Right First Time, Continuous Improvement and value stream mapping in maintenance activities, risks in the introduction and organization of TPM
- Planning & scheduling of maintenance events – the use of RCM software as a structured process to develop asset maintenance plans
- Achieve more with more: Increased understanding of asset maintainability with improved master data
- Providing transparency to all by using smart business intelligence tools for plant maintenance
- Integrated approach to budgeting, maintenance strategy optimisation and resource forecasting
- Cost control strategies in maintenance: Effective planning and engineering of new plants, (pilot plants) design of plants, spare parts management and supplier relationship management in a validated environment
- Challenges in human error prevention in pharmaceutical engineering & technical operations
- Preparation and conduct of inspections and audits and embedding of processes in an overall maintenance strategy
- Indoor asset mapping & Mobile mapping systems
- Asset Care Excellence (ACE ) – Improving asset performance and asset lifecycle management with world-class
- Energy savings through targeted maintenance activities and integration in a total plant asset management system
- Sustaining efficiency through operational variance management
- Monitoring the ageing and life expectancy of equipment
- Predictive Maintenance – Condition Monitoring, Communications, Efficiency, Diagnostics
Speaker Panel:
- Dr. Lothar Döllinger, President Site Management & Technology Investments EMEA, Bayer AG / Germany
- Michael Teasdale, Senior Director Operation Excellence, Baxter BioScience / USA
- Lewis H. Sita, Director, GPO Engineering / Global Head Maintenance Excellence Program (MEP), Abbott Laboratories / USA
- Hans Werner Maier, Senior Director Asset Technology, DSM Nutritional Products / Switzerland
- Jean Paul Gossuin, Vice President, Head of Engineering & Technology, TechOps Merck Serono / Switzerland
- Giuseppe Mirra, Director Reliabilty & Maintenance Operations, Sanofi Pasteur / USA
- Sean Fitzpatrick, Manufacturing Technology & Engineering Director, Shire Pharmaceuticals / UK
- Oliver Kärst, Head of Technical Services, Warner Chilcott Deutschland GmbH / Germany
- Giovanni Mattoni, Plant Maintenance Business Area Leader, F. Hoffmann-La Roche AG / Switzerland
- Thomas Gosmann, Global Process Teamlead, Center of Excellence, Bayer HealthCare AG, Organization & Information / Germany
- Mark Granger, Plant Engineering Coordinator, AstraZeneca UK Operations
- Hans-Peter Vogels Director Quality & Manufacturing Meda Manufacturing GmbH / Germany
- Sewa Bhatt, Manager, Global Change Management & Workforce Lead Eli Lilly Research Project Management Office / USA
- Ernst Keck, Head Asset Performance Management Roche Diagnostics / Germany
- Rudi Frederix, I&C Lead & Member of the Genzyme ACE Program Genzyme Flandern / Belgium
- Jo Dalle, Technical Operations Director EMEA Genzyme Flandern / Belgium
- Laurence Plant, Principal Consultant, ABB / UK
- Martin Brown, Principal Consultant, ABB / UK
- Mike Gehloff, Strategic Account Director, GP Allied / UK
- Paul Ludorf, Head of Technical Department, Rottapharm / Ireland
- Frank Hirsch, Manager Support Center & Finishing Operations, Abbott GmbH & Co KG / Germany
Our Business Partner of Pharma M2R Minds 2012:
- ABB Consulting
Become a Business Partner of the Pharma M2R Minds 2012.
Learn how your company can take advantage of brand new benefits which you will only experience at our Pharma M2R Minds 2012.
For further information please contact Jörg Thinius, Director Partner Management at:
•Phone: +49 (0) 30 52 10 70 3 – 33
•E-Mail: joerg.thinius(at)we-conect.com
You are not able to participate in the conference, but are still interested in the topics? Order our conference documentation for 495 Euro + VAT.
Themen in dieser Pressemitteilung:
pharma-m2r-minds-2012
5th-6th-november-2012
maritim-proarte-hotel-berlin
germany
conference
congress
rcm
maintenance
reliability-centered-maintenance
fmea
failure-mode-effects-analysis
oee
overall-equipment-effectiveness
kpi-s
operationa
Unternehmensinformation / Kurzprofil:
we.CONECT Global Leaders is an international B2B conference and training provider that is focused on the development and deployment of strategies, tactics and solutions to allow customers the maximum value in their daily operations.
At the heart of everything we do is a basic trust in the power of the people with whom we work.
We care about our customers, our partners and our employees. This is our driving force and an integral part of our work.
We invest our time, our knowledge and our strength in developing a product that is much more than a conference. This philosophy requires a climate in which ideas can grow with your business and your people. Promoting participation in open thinking, fresh ideas and innovative approaches. New faces are always welcome!
At we.CONECT the people and the intensive exchange of knowledge come first. The know-how behind we.CONECT is that of our employees. In the areas of research, marketing and event organization our experiences sum up to more than 40 years. We believe that there is no substitute for interactive learning, sharing ideas, knowledge and best practices. We use our formats and interaction to help our clients achieve their individual goals. we.CONECT organizes more than 20 premium conferences per year with a focus on best practices of world leaders and hidden champions, latest challenges, trends and technologies and discusses future developments on a unique networking platform.
We set high standards In the development of our conferences, communicate with renowned managers and executives and create unique live events.
We are constantly able to find new and innovative ways to design high-quality, market-focused events and provide them as required. If you have any suggestions or want to share your opinion, contact us via info(at)we-conect.com.
Peter Haack
Marketing Development Manager
__________________________
we.CONECT Global Leaders GmbH
Gertraudenstr. 10-12 | 10178 Berlin, Germany
Phone: +49 (0)30 52 10 70 3 – 0
Fax: +49 (0)30 52 10 70 3 – 30
Email: peter.haack(at)we-conect.com
Web: http://pharma-maintenance.we-conect.com
Calendar: Mark the Pharma M2R Minds 2012 in your calendar
Video: http://www.youtube.com/watch?v=CX4O89BePBY
To unsubscribe, please click here [Event.lm9]
Terms & Conditions
Datum: 06.08.2012 - 03:31 Uhr
Sprache: Deutsch
News-ID 1139462
Anzahl Zeichen: 0
contact information:
Contact person: Ewelina Feil
Town:
Berlin
Phone: +49 (0)30 52 10 70 3 0
Kategorie:
Pharmaceuticals & Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 545 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Pharma M2R Minds 2012
"
steht unter der journalistisch-redaktionellen Verantwortung von
we.CONECT Global Leaders GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
